BioNexus Gene Lab Corp. Operating Lease, Expense
BioNexus Gene Lab Corp. (BGLC) reported Operating Lease, Expense of $36.55 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-14
- BioNexus Gene Lab Corp. operating lease, expense for the quarter ending 2026-06-30 was $18.15K, a 5.57% increase year-over-year.
- BioNexus Gene Lab Corp. operating lease, expense for the quarter ending 2026-03-31 was $18.41K, a 9.93% increase year-over-year.
- BioNexus Gene Lab Corp. operating lease, expense for the quarter ending 2025-12-31 was $17.73K, a 4.81% increase year-over-year.
- BioNexus Gene Lab Corp. operating lease, expense for the quarter ending 2025-09-30 was $17.45K, a 6.01% decline year-over-year.
- BioNexus Gene Lab Corp. operating lease, expense for fiscal 2025 was $69.11K, a 13.71% increase from fiscal 2024.
- BioNexus Gene Lab Corp. operating lease, expense for fiscal 2024 was $60.78K, a 97.44% increase from fiscal 2023.
- BioNexus Gene Lab Corp. operating lease, expense for fiscal 2023 was $30.78K, a 526.56% increase from fiscal 2022.
- BioNexus Gene Lab Corp. operating lease, expense for fiscal 2022 was $4.91K, a 81.69% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $18.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $36.55K 10-Q · filed 2026-08-14 | $54.28K derived: sum of 3 quarters · filed 2026-08-14 | $71.73K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $18.41K 10-Q · filed 2026-05-15 | $36.13K derived: sum of 2 quarters · filed 2026-05-15 | $53.58K derived: sum of 3 quarters · filed 2026-05-15 | $70.77K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $17.73K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $35.18K derived: sum of 2 quarters · filed 2026-04-14 | $52.37K derived: sum of 3 quarters · filed 2026-08-14 | $69.11K 10-K · filed 2026-04-14 | ||||
| 2025-09-30 | $17.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $34.64K derived: sum of 2 quarters · filed 2026-08-14 | $51.39K 10-Q · filed 2025-11-14 | $68.30K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $17.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $33.93K 10-Q · filed 2026-08-14 | $50.84K derived: sum of 3 quarters · filed 2026-08-14 | $69.41K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $16.74K 10-Q · filed 2026-05-15 | $33.65K derived: sum of 2 quarters · filed 2026-05-15 | $52.23K derived: sum of 3 quarters · filed 2026-05-15 | $66.04K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $16.91K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $35.48K derived: sum of 2 quarters · filed 2026-04-14 | $49.30K derived: sum of 3 quarters · filed 2026-04-14 | $60.78K 10-K · filed 2026-04-14 | ||||
| 2024-09-30 | $18.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $32.39K derived: sum of 2 quarters · filed 2025-11-14 | $43.87K 10-Q · filed 2025-11-14 | $8.36K 10-Q · filed 2024-11-15 | $71.34K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $13.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | $25.30K 10-Q · filed 2025-08-18 | $4.59K 10-Q · filed 2024-08-14 | $52.77K derived: sum of 3 quarters · filed 2025-08-18 | $54.80K derived: sum of 4 quarters · filed 2025-08-18 | |||
| 2024-03-31 | $11.48K 10-Q · filed 2025-05-15 | $2.03K 10-Q · filed 2024-05-15 | $38.95K derived: sum of 2 quarters · filed 2025-05-15 | $40.99K derived: sum of 3 quarters · filed 2025-05-15 | $41.41K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $27.47K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $29.51K derived: sum of 2 quarters · filed 2025-04-15 | $29.93K derived: sum of 3 quarters · filed 2025-04-15 | $30.78K 10-K · filed 2025-04-15 | $5.61K 10-K · filed 2024-04-16 | |||
| 2023-09-30 | $2.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | $2.46K derived: sum of 2 quarters · filed 2024-11-15 | $3.31K 10-Q · filed 2024-11-15 | $3.44K 10-Q/A · filed 2024-03-26 | $6.87K derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2023-06-30 | $420.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.27K 10-Q · filed 2024-08-14 | $1.56K 10-Q · filed 2023-08-16 | $4.83K derived: sum of 3 quarters · filed 2024-08-14 | $5.24K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $855.00 10-Q · filed 2024-05-15 | $4.41K derived: sum of 2 quarters · filed 2024-05-15 | $4.82K derived: sum of 3 quarters · filed 2024-05-15 | $5.24K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $3.56K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | $3.96K derived: sum of 2 quarters · filed 2024-04-16 | $4.38K derived: sum of 3 quarters · filed 2024-04-16 | $4.91K 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | $406.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | $829.00 derived: sum of 2 quarters · filed 2024-03-26 | $1.36K 10-Q/A · filed 2024-03-26 | $1.27K 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $423.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $952.00 10-Q · filed 2022-08-15 | ||||||
| 2022-03-31 | $529.00 10-Q · filed 2022-05-16 | |||||||
| 2021-12-31 | $2.70K 10-K · filed 2023-03-31 | |||||||
| 2020-12-31 | $2.58K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-04-06 | $2.69K derived: sum of 2 quarters · filed 2022-04-06 | $3.00K derived: sum of 3 quarters · filed 2022-04-06 | $3.38K 10-K · filed 2022-04-06 | $61.13K 10-K · filed 2021-03-30 | |||
| 2020-09-30 | $115.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09 | $802.00 10-Q · filed 2020-11-03 | $802.00 10-Q/A · filed 2020-11-09 | |||||
| 2020-06-30 | $309.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $687.00 10-Q · filed 2020-08-11 | ||||||
| 2020-03-31 | $378.00 10-Q · filed 2020-05-08 | |||||||
| 2019-12-31 | $2.00K 10-Q/A · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |